Pharma Mar (XMAD:PHM) Pre-Tax Income : €-3.2 Mil (TTM As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Pharma Mar Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Pharma Mar's pretax income for the three months ended in Mar. 2024 was €-2.8 Mil. Its pretax income for the trailing twelve months (TTM) ended in Mar. 2024 was €-3.2 Mil. Pharma Mar's pretax margin was -7.30%.

During the past 13 years, Pharma Mar's highest Pretax Margin was 53.94%. The lowest was -25.23%. And the median was 0.39%.

Pharma Mar Pre-Tax Income Historical Data

The historical data trend for Pharma Mar's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharma Mar Pre-Tax Income Chart

Pharma Mar Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Pre-Tax Income

Get a 7-Day Free Trial

-21.65

145.61

95.13

43.79

-3.62

Pharma Mar Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Pre-Tax Income	Get a 7-Day Free Trial															-3.22	4.50	1.57	-6.47	-2.77

Competitive Comparison of Pharma Mar's Pre-Tax Income

For the Biotechnology subindustry, Pharma Mar's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharma Mar's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharma Mar's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Pharma Mar's Pre-Tax Income falls into.

Pharma Mar Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Pharma Mar's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-4.098	+	0	+	-2.416	+	4.103	+	-1.212
	=	-3.6

Pharma Mar's Pretax Income for the quarter that ended in Mar. 2024 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-4.33	+	0	+	0	+	1.529	+	0.031
	=	-2.8

Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-3.2 Mil.

Pharma Mar (XMAD:PHM) Pre-Tax Income Explanation

Pharma Mar's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	-2.77	/	37.966
	=	-7.30%

During the past 13 years, Pharma Mar's highest Pretax Margin was 53.94%. The lowest was -25.23%. And the median was 0.39%.

Pharma Mar Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Pharma Mar's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharma Mar (XMAD:PHM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharma Mar SA (XMAD:PHM) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

PHMMF:USA PHMe:UK 0RC6:UK

Address

Avenida de los Reyes, 1, Poligono Industrial La Mina-norte, Colmenar Viejo, Madrid, ESP, 28770

Website

http://www.pharmamar.com

Pharma Mar SA is engaged in the research, development, production, and commercialization of bio-active principles of marine origin for application in oncology. It also produces and market insecticides and air fresheners for household use, household products, wood treatment and decoration products, paints, and similar products. Its operating business segments are Oncology, Diagnostics, Consumer chemicals, and RNAi. The company obtains its revenues from two main areas: biopharmaceuticals and consumer chemicals, but the biopharmaceuticals is the main line of business.